TRACON PHARMACEUTICALS, INC. SEVERANCE PLAN SEVERANCE AGREEMENTSeverance Agreement • March 1st, 2017 • Tracon Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledMarch 1st, 2017 Company Industry JurisdictionThis Severance Agreement (the “Agreement”) is entered into by and between H. Casey Logan (“you” or “your”) and TRACON Pharmaceuticals, Inc. (the “Company”) pursuant to the TRACON Pharmaceuticals, Inc. Severance Plan (“Plan”). Capitalized terms used herein but not otherwise defined have the meanings set forth in the Plan.
TRACON PHARMACEUTICALS, INC. AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • March 1st, 2017 • Tracon Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledMarch 1st, 2017 Company Industry JurisdictionThis Amended and Restated Employment Agreement (the “Agreement”) is made and entered into effective as of February 27, 2017 (the “Effective Date”), by and between TRACON Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and H. Casey Logan (the “Executive”). The Company and Executive are hereinafter collectively referred to as the “Parties”, and individually referred to as a “Party”. From and following the Effective Date, this Agreement along with the Severance Agreement entered into by and between Executive and the Company concurrently with this Agreement (the “Severance Agreement”) shall replace and supersede that certain Employment Agreement between Executive and Company entered into as of February 18, 2013 (the “Prior Agreement”). Certain capitalized terms used in this Agreement are defined in Section 11.
TRACON PHARMACEUTICALS, INC. AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • March 1st, 2017 • Tracon Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledMarch 1st, 2017 Company Industry JurisdictionThis Amended and Restated Employment Agreement (the “Agreement”) is made and entered into effective as of February 27, 2017 (the “Effective Date”), by and between TRACON Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Charles P. Theuer (the “Executive”). The Company and Executive are hereinafter collectively referred to as the “Parties”, and individually referred to as a “Party”. From and following the Effective Date, this Agreement shall replace and supersede that certain Amended and Restated Employment Agreement between Executive and Company entered into as of May 8, 2015 (the “Prior Agreement”). Certain capitalized terms used in this Agreement are defined in Section 11.